Dexamethasone + Dexmedetomidine for Post-Op ACL Repair Pain
(AADDCToR Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines how two drugs, dexamethasone (a corticosteroid) and dexmedetomidine (a sedative), reduce pain after ACL (knee ligament) surgery. Researchers aim to determine if using these drugs alone or together eases recovery by reducing pain. Participants will receive either one of the drugs, both drugs combined, or a placebo (inactive treatment). Individuals who have undergone ACL repair and do not have diabetes, chronic pain, or a history of drug dependence may be suitable for this study. As a Phase 4 trial, the study focuses on understanding how these FDA-approved and effective treatments can benefit more patients.
Do I have to stop taking my current medications for the trial?
The trial protocol does not specify if you need to stop taking your current medications. However, if you have a history of long-term opioid use or certain medical conditions, you may not be eligible to participate.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. Please consult with the trial coordinators for guidance.
What is the safety track record for these treatments?
Research has shown that dexamethasone and dexmedetomidine are generally safe and effective for managing post-surgical pain. Studies have found that dexamethasone reduces pain and decreases the need for painkillers after surgery. It also helps with swelling and lessens nausea and fatigue.
For dexmedetomidine, research indicates it lowers pain levels and improves recovery after surgery. It stabilizes vital signs and enhances overall treatment effectiveness. When used together, dexamethasone and dexmedetomidine provide better pain relief than using either one alone.
Both treatments have a strong safety record in humans, supported by multiple studies. Participants in past trials generally tolerated these treatments well, with few serious side effects reported.12345Why are researchers enthusiastic about this study treatment?
Researchers are excited about combining dexamethasone and dexmedetomidine for post-op ACL repair pain because this pairing offers a potentially enhanced approach to pain management. Unlike traditional pain treatments like opioids, which can have significant side effects and addiction risks, this combination targets pain through anti-inflammatory effects (dexamethasone) and sedation with analgesia (dexmedetomidine). Dexamethasone reduces swelling and inflammation, while dexmedetomidine provides calming and pain-relief effects, potentially reducing the need for opioids. Additionally, the use of these agents together could offer a more balanced and effective pain control strategy, minimizing side effects and improving recovery experiences for patients.
What evidence suggests that this trial's treatments could be effective for post-op ACL repair pain?
Research has shown that dexamethasone can reduce swelling and ease pain, nausea, and tiredness after surgery. It also provides longer-lasting pain relief. In this trial, some participants will receive dexamethasone alone, while others will receive dexmedetomidine alone. Studies indicate that dexmedetomidine effectively reduces pain and decreases the need for other pain medications after surgery. Additionally, one arm of this trial will test the combination of both dexamethasone and dexmedetomidine, which might improve pain control further, potentially reducing moderate-to-severe pain by an additional 20%. These treatments aim to make recovery from ACL repair surgery less painful and more comfortable.16789
Who Is on the Research Team?
Richard Brull, MD
Principal Investigator
Women's College Hospital
Are You a Good Fit for This Trial?
This trial is for English-speaking individuals with a BMI under 40, who are in generally good health (ASA 1-3), and are about to undergo surgery for an Anterior Cruciate Ligament (ACL) injury.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo ACL repair surgery with adductor canal block and receive either dexamethasone, dexmedetomidine, their combination, or placebo to evaluate postoperative analgesia
Immediate Postoperative Monitoring
Participants are monitored for pain relief and opioid consumption in the PACU and up to 24 hours post-surgery
Follow-up
Participants are monitored for safety, effectiveness, and complications related to the nerve block and opioid use
What Are the Treatments Tested in This Trial?
Interventions
- Dexamethasone
- Dexmedetomidine
- Saline
Find a Clinic Near You
Who Is Running the Clinical Trial?
Women's College Hospital
Lead Sponsor
University Health Network, Toronto
Collaborator